Caleco Pharma Corp.
Description Caleco Pharma Corp. engages in the acquisition and development of over-the-counter medication, and Food and Drug Administration approved pharmaceuticals. It owns a proprietary technology designed to treat moderate to severe liver maladies, such as elevated liver enzymes and the Hepatitis C viral infection (the Liver Health Formula) as an over-the-counter medication, and as the United States Food and Drug Administration approved pharmaceutical. The companys intellectual property covering the Liver Health Formula comprises patent applications in the United States, Canada, and Europe, as well as four European Drug Master File applications. It also develops food supplements, hair and dermatological products, energy drinks, and chewing gum using the formulations of its Liver Health Formula. In addition, Caleco holds the right to develop, commercialize, market, and distribute five compounds, including AOF, AH-FLO, JHF, HGF, and NB-VAL40 derived from plant extracts in North and South America pursuant to a license agreement with Natac Biotech S.L., a Spanish biotechnology corporation engaged in the research and development of health related products. The company was formerly known as Blackstone Lake Minerals Inc. and changed its name to Caleco Pharma Corp. in August 2009. Caleco Pharma Corp. is based in Long Valley, New Jersey. To view the detailed information, you need to SUBSCRIBE with us. |
 |